Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial

Authors/contributors
Publication
JAMA Oncology
Date
2022-03-01
Notes

Key Points

  • The study compared a 5-day prophylactic antibiotic regimen with a 1-day regimen in patients undergoing surgical resection and endoprosthetic reconstruction for lower extremity bone tumors.
  • No statistically significant difference in surgical site infection rates between the 5-day and 1-day regimens.
  • Significantly higher rate of serious antibiotic-related complications, mainly Clostridioides difficile–associated colitis, in the 5-day regimen group.

Strengths

  • Randomized clinical trial design with concealed randomization and blinding for minimizing biases.
  • Low loss to follow-up (5%).
  • Broad eligibility criteria increase generalizability.

Limitations

  • Low enrollment at some clinical sites due to the rarity of bone tumors.
  • Imbalance in preoperative chemotherapy between groups, although adjusted analyses yielded similar results.
  • Protocol deviations occurred, mostly due to early hospital discharge.

Citation
1.
The Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) Investigators, Ghert M, Schneider P, et al. Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial. JAMA Oncol. 2022;8(3):345.